NVCR 16.86 (+2.31%)
JE00BYSS4X48• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. NVCR

NovoCure (NVCR) Competitor Comparison

We are evaluating the key criteria listed to compare NovoCure (NVCR) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

23 / 44

Gross Profits

19 / 40

Total Revenue

21 / 43

EBITDA

44 / 44

Free Cashflow

14 / 44

Quick Ratio

5 / 44

Earnings per Share

34 / 44

Dividend yield

0 / 13

Total Cash

7 / 44

Performance 3 years

40 / 44

Performance 5 years

37 / 44

Performance 10 years

29 / 44

Linearity 3 years

35 / 44

Linearity 5 years

31 / 44

Linearity 10 years

2 / 44

Total Rank

20 / 44

Dividend Rank

31 / 44

Valuation Rank

26 / 44

Piotroski Rank

23 / 44

Muliplier Rank

19 / 44

Linearity 10 years - NVCR ranking 2 / 44

These are the competitors of NovoCure in the industry Medical Instruments & Supplies ranked by linearity 10 years
1. NexGel NXGL
67.17
2. NovoCure NVCR
21.5
3. Utah Medical Products UTMD
17.31
4. Baxter BAX
17.28
5. Bausch & Lomb BLCO
14.94
6. Envista Holdings NVST
9
7. Atrion ATRI
7.3
8. Teleflex TFX
5.74
9. Ansell PD1.F
5.27
10. OraSure Technologies OSUR
5
11. Harvard Bioscience HBIO
4.29
12. AngioDynamics ANGO
4.04
13. Dentsply Sirona XRAY
3.74
14. Becton, Dickinson BDX
3.68
15. Alcon ALC
3.68
16. Staar Surgical STAA
3.54
17. Nephros NEPH
3.13
18. AtriCure ATRC
2.86
19. ICU Medical ICUI
2.81
20. iRhythm Technologies IRTC
2.3
21. Warby Parker WRBY
2.2
22. Akoya Biosciences AKYA
1.94
23. Ekso Bionics Holdings EKSO
1.71
24. Haemonetics HAE
1.68
25. Femasys FEMY
1.52
26. Cooper Companies COO
1.49
27. Pulse Biosciences PLSE
1.44
28. Microbot Medical MBOT
1.29
29. electroCore ECOR
1.26
30. Intuitive Surgical ISRG
1.25
31. NeuroMetrix NURO
1.23
32. Predictive Oncology POAI
1.15
33. Hologic HOLX
1.12
34. Masimo MASI
0.98
35. KORU Medical Systems KRMD
0.93
36. Steris STE
0.84
37. Repligen RGEN
0.81
38. BioLife Solutions BLFS
0.72
39. ResMed RMD
0.6
40. West Pharmaceutical Services WST
0.53
41. Pro-Dex PDEX
0.41
42. Glaukos GKOS
0.36
43. LeMaitre Vascular LMAT
0.27
44. Merit Medical Systems MMSI
0.24
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.